Stanley Lee possesses a robust background in process engineering and technical support, with significant experience in the biotechnology and pharmaceutical industries. As a researcher at Sinopharm Group Company Limited from January 2004 to January 2006, Stanley contributed to early-stage scientific projects. At GRAIL from 2018 to 2020, Stanley advanced to the role of Manager of Reagent Process Development, leading teams focused on Multi-Cancer Early Detection IVD assay reagents. Prior positions include Senior Technical Specialist at Danaher Corporation, where Stanley developed sales models and managed technical support processes for the Asia Pacific market, and an Innovation Leadership Program Associate at Dow, where market strategies for new technologies were developed. Educational credentials include a Master of Science in OCPM, Molecular Biology from Cornell University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices